Literature DB >> 565018

Catalepsy induced by intrastriatal injections of delta9-THC and 11-OH-delta9-THC in the rat.

A L Gough, J E Olley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 565018     DOI: 10.1016/0028-3908(78)90126-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  7 in total

1.  Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol.

Authors:  Matthew J Pava; Emily M Blake; Stephen T Green; Brandon J Mizroch; Patrick J Mulholland; John J Woodward
Journal:  Psychopharmacology (Berl)       Date:  2011-06-24       Impact factor: 4.530

Review 2.  Therapeutic potential of cannabinoids in CNS disease.

Authors:  J Ludovic Croxford
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels.

Authors:  Zsuzsanna Sidló; Patricia H Reggio; Margaret E Rice
Journal:  Neurochem Int       Date:  2007-07-22       Impact factor: 3.921

4.  Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications.

Authors:  Giorgio Marchese; Paola Casti; Stefania Ruiu; PierLuigi Saba; Angela Sanna; GianLuca Casu; Luca Pani
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

5.  Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat.

Authors:  W R Prescott; L H Gold; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Endocannabinoid-dopamine interactions in striatal synaptic plasticity.

Authors:  Brian N Mathur; David M Lovinger
Journal:  Front Pharmacol       Date:  2012-04-19       Impact factor: 5.810

7.  Biological bases for a possible effect of cannabidiol in Parkinson's disease.

Authors:  Nilson C Ferreira-Junior; Alline C Campos; Francisco S Guimarães; Elaine Del-Bel; Patrícia M da R Zimmermann; Liberato Brum Junior; Jaime E Hallak; José A Crippa; Antonio W Zuardi
Journal:  Braz J Psychiatry       Date:  2019-07-15       Impact factor: 2.697

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.